SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001615774-15-000017
Filing Date
2015-01-05
Accepted
2015-01-05 09:24:48
Documents
1
Group Members
CORONADO BIOSCIENCES, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D s100608_sc13d.htm SC 13D 75333
  Complete submission text file 0001615774-15-000017.txt   76726
Mailing Address 375 PARK AVE NEW YORK NY 10152
Business Address
ROSENWALD LINDSAY A MD (Filed by) CIK: 0000941841 (see all company filings)

Type: SC 13D

Mailing Address 24 NEW ENGLAND EXECUTIVE PARK SUITE 105 BURLINGTON MA 01803
Business Address 24 NEW ENGLAND EXECUTIVE PARK SUITE 105 BURLINGTON MA 01803 781-652-4500
CB Pharma Acquisition Corp. (Subject) CIK: 0001619551 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1130
Type: SC 13D | Act: 34 | File No.: 005-88466 | Film No.: 15502628
SIC: 6770 Blank Checks